These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30607440)
1. Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis. Asano Y; Takeuchi T; Okubo H; Saigo C; Kito Y; Iwata Y; Futamura M; Yoshida K J Mol Med (Berl); 2019 Feb; 97(2):257-268. PubMed ID: 30607440 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer. Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427 [TBL] [Abstract][Full Text] [Related]
3. Expression and localization of estrogen receptor in human breast cancer and its clinical significance. Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640 [TBL] [Abstract][Full Text] [Related]
4. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734 [TBL] [Abstract][Full Text] [Related]
5. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction. Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408 [TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626 [TBL] [Abstract][Full Text] [Related]
7. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression. Zhao D; Zhang Y; Wang N; Yu N Cancer Biomark; 2017 Sep; 20(3):247-254. PubMed ID: 28946559 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Chakravarty G; Moroz K; Makridakis NM; Lloyd SA; Galvez SE; Canavello PR; Lacey MR; Agrawal K; Mondal D Exp Biol Med (Maywood); 2011 Feb; 236(2):145-55. PubMed ID: 21321311 [TBL] [Abstract][Full Text] [Related]
9. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Suzuki T; Inoue A; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H Endocr Relat Cancer; 2007 Jun; 14(2):279-92. PubMed ID: 17639044 [TBL] [Abstract][Full Text] [Related]
10. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression. Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959 [TBL] [Abstract][Full Text] [Related]
11. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582 [TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of β-catenin in invasive ductal breast carcinomas. Abd El-Rehim D; Ali MM J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570 [TBL] [Abstract][Full Text] [Related]
13. gamma-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells. Liu CX; Ranganathan S; Robinson S; Strickland DK J Biol Chem; 2007 Mar; 282(10):7504-11. PubMed ID: 17227771 [TBL] [Abstract][Full Text] [Related]
14. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS; Kim SW Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359 [TBL] [Abstract][Full Text] [Related]
15. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status. El Sharkawy SL; Farrag AR Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734 [TBL] [Abstract][Full Text] [Related]
16. Targeting claudin-4 enhances chemosensitivity in breast cancer. Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991 [TBL] [Abstract][Full Text] [Related]
17. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer. Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211 [TBL] [Abstract][Full Text] [Related]
18. Correlation between nuclear grade and biological prognostic variables in invasive breast cancer. Yang Q; Mori I; Sakurai T; Yoshimura G; Suzuma T; Nakamura Y; Nakamura M; Taniguchi E; Tamaki T; Umemura T; Kakudo K Breast Cancer; 2001; 8(2):105-10. PubMed ID: 11342982 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194 [TBL] [Abstract][Full Text] [Related]
20. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. Zhang R; Zhang H; Wei H; Luo X J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]